- Home
- SWVL vs PYPD Comparison
SWVL vs PYPD Comparison
Compare SWVL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- PYPD
- Stock Information
- Founded
- SWVL 2017
- PYPD 2008
- Country
- SWVL United Arab Emirates
- PYPD Israel
- Employees
- SWVL N/A
- PYPD N/A
- Industry
- SWVL Business Services
- PYPD Medical/Dental Instruments
- Sector
- SWVL Consumer Discretionary
- PYPD Health Care
- Exchange
- SWVL Nasdaq
- PYPD Nasdaq
- Market Cap
- SWVL 44.5M
- PYPD 36.0M
- IPO Year
- SWVL N/A
- PYPD 2020
- Fundamental
- Price
- SWVL $4.79
- PYPD $3.52
- Analyst Decision
- SWVL
- PYPD Strong Buy
- Analyst Count
- SWVL 0
- PYPD 5
- Target Price
- SWVL N/A
- PYPD $11.40
- AVG Volume (30 Days)
- SWVL 22.8K
- PYPD 199.2K
- Earning Date
- SWVL 07-22-2025
- PYPD 08-13-2025
- Dividend Yield
- SWVL N/A
- PYPD N/A
- EPS Growth
- SWVL N/A
- PYPD N/A
- EPS
- SWVL N/A
- PYPD N/A
- Revenue
- SWVL $17,207,362.00
- PYPD N/A
- Revenue This Year
- SWVL N/A
- PYPD N/A
- Revenue Next Year
- SWVL N/A
- PYPD N/A
- P/E Ratio
- SWVL N/A
- PYPD N/A
- Revenue Growth
- SWVL N/A
- PYPD N/A
- 52 Week Low
- SWVL $2.40
- PYPD $2.30
- 52 Week High
- SWVL $8.05
- PYPD $4.42
- Technical
- Relative Strength Index (RSI)
- SWVL 64.82
- PYPD 47.79
- Support Level
- SWVL $4.08
- PYPD $3.34
- Resistance Level
- SWVL $4.89
- PYPD $3.53
- Average True Range (ATR)
- SWVL 0.47
- PYPD 0.13
- MACD
- SWVL 0.07
- PYPD -0.05
- Stochastic Oscillator
- SWVL 91.60
- PYPD 6.82
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.